Information Density: Invitae – Signal Evidence & AI Readability

[IMG: Invitae genetic testing homepage - image of patient]
[IMG: Invitae genetic testing homepage - image of patient]
[H1] Bringing the future of genetic testing within reach
Together, Invitae (“in-VEE-tay”) and Labcorp make it easier to access genetic data, uncover personal health insights and deliver the right care for each patient's needs.
[IMG: Invitae and Labcorp]
[H2] More personalized care starts here
Invitae and Labcorp have come together to help deliver more breakthroughs for more patients.More about us
[IMG: Female holding child patient – Invitae genetic testing]
[H2] Meaningful insights
We're always looking to support you with our dedicated genetic testing services and tools. Let our genetic counselors help you translate results into potential next steps.
[IMG: Male patient in blue long sleeve shirt – Invitae genetic testing]
[H2] Expanded access
With coverage by most health plans and Labcorp's nationwide network of conveniently located patient service centers, genetic testing is more accessible for more patients.
[IMG: Female patient in blue blouse – Invitae genetic testing]
[H2] Trusted expertise
Together with Labcorp, we’re leaders in advancing genetic testing and treatments. We help you gain a more complete picture of your health.
[IMG: Choosen by 5+ million patients and their providers - Invitae genetic testing]
[H2] Chosen by 5+ million patients and their providers
[H3] Let's get started
Contact us to learn more about how we can meet your genetic testing needs.Get in touch
[H2] Have questions?
Now that Invitae is a part of Labcorp, what should I know? Working together helps us deliver on our mission to improve health and improve lives. With coverage by most health plans and Labcorp's nationwide network of conveniently located patient service centers, we're working to make innovative genetic testing more accessible. Our combined industry leadership will continue to advance the field of genetics while improving patient care and access. Learn moreHow are Invitae’s genetic tests different from other genetic tests?Invitae’s broad test offerings inform every stage of life for patients and their families, providing a single, reliable source for genetic testing. Flexible billing options and built-in support enable more clinicians and patients to make confident health decisions based on results. Explore tests in Invitae’s test catalog.Are genetic counseling services available to all patients undergoing Invitae testing?A genetic counseling session is available to answer questions about genetic testing and results. This is included at no additional cost to patients located in the US, US territories, and Canada who have ordered a currently offered Invitae genetic test. Learn more on this genetic counseling page.Who can I contact today?To speak directly with client services, email clientservices@invitae.com at any time or call 800-436-3037 Monday through Friday, 5:00 am to 5:00 pm Pacific time. Visit our contact page to find more information.

[H1] Papers & presentations
We believe there is a new gold standard today, one that includes both high-quality testing and a dedication to improve medicine.
[H2] Explore our Expanded Knowledge Library on Labcorp.com
We've moved our educational resources to a new, dedicated location. Find publications, conference posters and presentation, webinars, white papers, case studies, and more — all in one place to support you. Search our knowledge library

[H1] We’re here to help
Our dedicated team is here to support you every step of the way
[IMG: Icon of a Man – Contact Invitae genetic testing]
[H3] For patients & individuals
Find answers to common questions about the genetic testing process, results, genetic counseling, and more.Learn more
[IMG: Icon of a Woman Provider – Contact Invitae genetic testing]
[H3] For providers
Find answers to questions about ordering, billing, specimen collection and shipping, clinical support, technology, and much more.Learn more

[H1] Help personalize your patients’ cancer treatment
Explore testsContact us
[IMG: Invitae Labcorp Cancer Patient]
[H3] Breast cancer
Transforming breast cancer care with genetic testing Hereditary cancer genetic testing may allow for more personalized care options and targeted therapies, 2,3 which may improve outcomes in patients and their families.1 in 8 patients with breast cancer have a disease-causing (pathogenic) gene variant that may impact clinical management recommendations.1,3,4The American Society of Breast Surgeons (ASBrS) recommends genetic testing be made available to all patients with breast cancer.5Over 75% of breast cancer patients with positive genetic results had at least one change in clinical recommendations.2Start a STAT order
[H3] Colorectal cancer
Optimizing colorectal cancer care with genetic testing Genetic testing is underutilized in patients with colorectal cancer despite insurance coverage.6There are more than one million colorectal cancer survivors in the United States, and the majority haven’t undergone hereditary cancer genetic testing.7,81 in 7 patients with colorectal cancer have a disease-causing gene variant that may impact medical management 1,6,9Hereditary cancer genetic testing can optimize patient care and help: Assess future risk of colorectal cancer and other cancer types 1,6 10Inform starting age and frequency of screenings such as colonoscopies 1,6,10Inform surgical options for patients with Lynch syndrome 1, 6Inform treatment options for patients with advanced disease 1Understand potential cancer risks for family members 1Start an order
[H3] Ovarian cancer
Guiding ovarian cancer care with genetic testingHereditary genetic test results are important for identifying patients who need targeted therapy. Targeted treatments like PARP inhibitors (sometimes preceded by platinum-based chemotherapy) can improve progression-free survival outcomes in both frontline and recurrent settings.111 in 5 patients with ovarian cancer have a gene variant that increases cancer risk.1Over 30% of women with disease-causing gene variants had no family history of breast or ovarian cancer, highlighting the importance of hereditary cancer genetic testing for all patients with ovarian cancer. 12Start an order
[H3] Pancreatic cancer
Revealing genetic insights for pancreatic cancer carePatients with pancreatic cancer could benefit from hereditary cancer genetic testing for customized clinical management recommendations13,141 in 7 patients with pancreatic cancer may have an inherited gene variant. 1,15,1678% of patients with pancreatic cancer who had disease-causing gene variants were potentially eligible for precision therapies or clinical trials.15
Start an order
[H3] Prostate cancer
Informing genetic insights for prostate cancerHigh-risk genetic variants, such as those in the BRCA2 gene, are associated with more biologically aggressive prostate cancer.18-20 In metastatic cases, survival among men with a BRCA1 or BRCA2 variant is half that of men with no genetic variant.19 Early detection may give your patients a better chance at improved outcomes.19,21,221 in 7 patients with prostate cancer have a disease-causing gene variant. 1,17,23As many as 70% of men with advanced or metastatic prostate cancer who had an actionable disease-causing hereditary cancer variant didn’t qualify for genetic testing based on family history.24Start an order
[IMG: Invitae Labcorp two women cancer patients embraced and happy]
[H2] Without hereditary cancer genetic testing, a crucial part of a patient’s cancer puzzle may be missing
Patients who have hereditary variants could benefit from tailored management, including colorectal (~15%), breast (~12%), ovarian (~20%), prostate (~13%), and pancreatic (~15%) cancer.1
[H2] A 2023 study published in JAMA suggests hereditary cancer genetic testing is underutilized in cancer care25
[IMG: 1 in 8 – breast cancer patients have genetic variant]
[H2] 1 in 8
[H3] cancer patients may have an inherited gene variant
A JAMA Oncology study found that hereditary cancer genetic testing for all patients with cancer—including colorectal, breast, ovarian, prostate, and pancreatic—uncovered disease-causing (pathogenic) inherited variants in 13.3% of patients.1
[IMG: 42%]
[H2] Nearly half of those patients didn’t have a suggestive family history
Testing only patients who meet guidelines criteria may lead to missing up to 42% of patients with an inherited disease-causing (pathogenic) variant.1 Genetic testing for all patients with cancer helps provide vital genetic information that can help guide their treatment.1
[H2] 28%
[H3] of patients with disease-causing (pathogenic) variants found in the highest-risk cancer genes had changes to medical management.1
In the JAMA Oncology study, 1 in 4 patients with a high-risk positive genetic result received genetics-based personalized cancer care.1Patient stories carousel, click to skip carouselCarousel item 1 of 3“When I found out about my cancer risk, I started getting mammograms 7 years ahead of schedule.”- Jenna began breast cancer screening at age 35 because of her resultsClick to go to carousel navigation
[IMG: Genetic Testing for Breast Cancer: Patient Sarah Colletti and Family]
“Once I found out I had [a] BRCA1 [gene variant], I just decided. I have a chance to do something.”- SarahRead Sarah's storyClick to go to carousel navigation
[IMG: Cancer patient]
“Now [my relatives] can make the decision, rather than letting cancer make the decision.”- MonicaRead Monica's storyClick to go to carousel navigationClick to go to carousel item 1(Current carousel item)Click to skip carousel navigationClick to go to carousel item 2Click to skip carousel navigationClick to go to carousel item 3Click to skip carousel navigation
[H2] Don't miss our groundbreaking research that helped show the life-changing potential of universal genetic testing for many cancer types.1
View study summary